Cancer Drug Resistance
Top
  1. Home
  2. About
  3. Editorial Board

Editorial Board

Editor-in-Chief

Editorial Board Members

  • Yehuda G. Assaraf
    Fred Wyszkowski Cancer Research Laboratory, Technion - Israel Institute of Technology, Haifa, Israel.
  • Carlos G. Ferreira
    Oncoclinica Group, Oncoclinical Institute, Rio de Janeiro, Brazil.
  • Jean-Pierre Gillet
    Department of Biomedical Sciences, Faculty of Medicine, University of Namur, Namur, Belgium.
  • Elisa Giovannetti
    Lab Medical Oncology, VU University Medical Center, Cancer Center Amsterdam, Amsterdam, The Netherlands; Cancer Pharmacology Lab, AIRC Start-Up Unit, University of Pisa, Pisa, Italy.
  • William Henry Gmeiner
    Department of Cancer Biology, Wake Forest University School of Medicine, Winston-Salem, NC, USA.
  • Ivana Grivicich
    Cancer Biology Laboratory, Lutheran University of Brazil, Canoas, Brazil.
  • Georg Hempel
    Clinical Pharmacy Group, Department of Pharmaceutical and Medical Chemistry, University of Münster, Münster, Germany.
  • Gerrit Jansen
    Department of Rheumatology, Amsterdam Rheumatology and immunology Center (ARC), Cancer Center Amsterdam, VU University Medical Center, Amsterdam, The Netherlands.
  • Markus Joerger
    Division of Medical Oncology, University of Basel, Basel, Switzerland.
  • Ganna Kalayda
    Institute of Pharmacy, University of Bonn, Bonn, Germany.
  • Hang Fai Kwok
    Faculty of Health Sciences, University of Macau, Macau, China.
  • Larry H. Matherly
    Barbara Ann Karmanos Cancer Institute, Wayne State University School of Medicine, Detroit, MI, USA.
  • Martin Michaelis
    School of Biosciences, University of Kent, Canterbury, UK.
  • Hans Minderman
    Division of Medicine, Roswell Park Cancer Institute, Buffalo, NY, USA.
  • Enrico Mini
    Department of Health Sciences, Section of Clinical Pharmacology and Oncology, University of Florence, Florence, Italy.
  • Patrycja Nowak-Sliwinska
    Molecular Pharmacology, School of Pharmaceutical Sciences (EPGL), University of Geneva, Geneva, Switzerland.
  • Paola Perego
    Fondazione IRCCS, Istituto Nazionale dei Tumori, Milan, Italy.
  • Roger M Phillips
    School of Pharmacy, University of Huddersfield, Huddersfield, UK.
  • Jose Antonio Rodriguez
    Department of Genetics, Physical Anthropology and Animal Physiology (School of Medicine) of the University of the Basque Country (UPV/EHU), Basque Country, Spain.
  • José Rueff
    Nova Medical School (NMS), Universidade Nova de Lisboa/Faculty of Medical Sciences, New University of Lisbon, Lisbon, Portugal.
  • Alexander Sparreboom
    Division of Pharmaceutics & Pharmaceutical Chemistry College of Pharmacy, The Ohio State University, Columbus, OH, USA.
  • Ulrike Stein
    Translational Oncology of Solid Tumors, Experimental and Clinical Research Center, Charité – Universitätsmedizin und Max-Delbrück-Centrum für Molekulare Medizin, Berlin, Germany.
  • Takanori Ueda
    Department of Hematology and Oncology, Faculty of Medical Sciences, University of Fukui, Fukui, Japan.
  • Robert C.A.M. van Waardenburg
    Department of Pharmacology and Toxicology, University of Alabama at Birmingham, Birmingham, AL, USA.
  • Takahiro Yamauchi
    Department of Hematology and Oncology, Faculty of Medical Sciences, University of Fukui, Fukui, Japan.
  • Nadia Zaffaroni
    Molecular Pharmacology Unit, Department of Experimental Oncology and Molecular Medicine, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy.
close